share_log

Altria | 10-Q: Q2 2024 Earnings Report

Altria | 10-Q: Q2 2024 Earnings Report

奥驰亚 | 10-Q：2024财年二季报
美股SEC公告 ·  2024/07/31 19:26

Moomoo AI 已提取核心信息

Altria Group reported Q2 2024 net revenues decreased 4.6% to $6.2 billion, while net earnings surged 79.6% to $3.8 billion, primarily driven by the $2.7 billion gain from the IQOS System commercialization rights sale. Adjusted earnings declined 3.8% to $2.3 billion due to lower operating income. The company recorded a $354 million non-cash impairment charge for the Skoal trademark.Smokeable products segment revenues fell 5.6% to $5.5 billion on lower shipment volumes, while oral tobacco products revenue grew 4.6% to $711 million despite volume declines. Marlboro maintained a 42.0% retail share, while on! nicotine pouches achieved 8.1% share of the oral tobacco category. The company expanded NJOY distribution to over 100,000 stores with 5.5% e-vapor category share.Altria reaffirmed its smoke-free transition vision, targeting 35% smoke-free volume growth and $5 billion in smoke-free revenues by 2028. The company maintained its progressive dividend policy targeting mid-single digit annual growth and completed a $2.4 billion accelerated share repurchase program using proceeds from the partial sale of its ABI stake.
Altria Group reported Q2 2024 net revenues decreased 4.6% to $6.2 billion, while net earnings surged 79.6% to $3.8 billion, primarily driven by the $2.7 billion gain from the IQOS System commercialization rights sale. Adjusted earnings declined 3.8% to $2.3 billion due to lower operating income. The company recorded a $354 million non-cash impairment charge for the Skoal trademark.Smokeable products segment revenues fell 5.6% to $5.5 billion on lower shipment volumes, while oral tobacco products revenue grew 4.6% to $711 million despite volume declines. Marlboro maintained a 42.0% retail share, while on! nicotine pouches achieved 8.1% share of the oral tobacco category. The company expanded NJOY distribution to over 100,000 stores with 5.5% e-vapor category share.Altria reaffirmed its smoke-free transition vision, targeting 35% smoke-free volume growth and $5 billion in smoke-free revenues by 2028. The company maintained its progressive dividend policy targeting mid-single digit annual growth and completed a $2.4 billion accelerated share repurchase program using proceeds from the partial sale of its ABI stake.
奥驰亚集团报告2024年第二季度净营业收入下降4.6%，降至62亿元，而净收益则激增79.6%，达到38亿元，主要得益于27亿元的IQOS系统商业化权利销售收益。由于运营收入下降，调整后收益下降3.8%，降至23亿元。公司记录了35400万元的非现金减值费用，涉及Skoal商标。可吸入产品部门的营业收入下降5.6%，降至55亿元，原因是出货量减少，而口腔烟草制品的收入尽管成交量下降，却增长了4.6%，达到71100万元。万宝路保持了42.0%的零售份额，而on!尼古丁袋在口腔烟草类别中达到了8.1%的市场份额。公司将NJOY的分销扩大到超过100,000家门店，电子烟类别份额为5.5%。奥驰亚重申其无烟转型愿景，计划到2028年实现35%的无烟成交量增长和50亿元的无烟营业收入。公司维持其渐进式分红政策，目标是中个位数的年度增长，并完成了一项24亿元的加速股份回购计划，使用部分出售其ABI股份的收益。
奥驰亚集团报告2024年第二季度净营业收入下降4.6%，降至62亿元，而净收益则激增79.6%，达到38亿元，主要得益于27亿元的IQOS系统商业化权利销售收益。由于运营收入下降，调整后收益下降3.8%，降至23亿元。公司记录了35400万元的非现金减值费用，涉及Skoal商标。可吸入产品部门的营业收入下降5.6%，降至55亿元，原因是出货量减少，而口腔烟草制品的收入尽管成交量下降，却增长了4.6%，达到71100万元。万宝路保持了42.0%的零售份额，而on!尼古丁袋在口腔烟草类别中达到了8.1%的市场份额。公司将NJOY的分销扩大到超过100,000家门店，电子烟类别份额为5.5%。奥驰亚重申其无烟转型愿景，计划到2028年实现35%的无烟成交量增长和50亿元的无烟营业收入。公司维持其渐进式分红政策，目标是中个位数的年度增长，并完成了一项24亿元的加速股份回购计划，使用部分出售其ABI股份的收益。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    22nd Century
    XXII
    -- 1.5100
    雾麻科技
    ISPR
    -- 2.930
    英美烟草
    BTI
    -- 40.510
    菲利普莫里斯
    PM
    -- 155.160
    奥驰亚
    MO
    -- 58.150
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股财报季火热：惊喜盈利能否延续涨势？
    1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？ 展开
    中国两会：会议前后股票价格走势的主要要点